...
首页> 外文期刊>Disease Prevention Daily. >Researchers Submit Patent Application, 'Hypodermic Needle Protective Cover', for Approval (USPTO 20210106767)
【24h】

Researchers Submit Patent Application, 'Hypodermic Needle Protective Cover', for Approval (USPTO 20210106767)

机译:研究人员提交专利申请,“皮下注射针防护罩”,批准(USPTO20210106767)

获取原文
获取原文并翻译 | 示例
           

摘要

2021 MAY 05 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - From Washington, D.C., NewsRx journalists report that a patent application by the inventors Sabo, Sharon (St. Louis, Mo); Sabo, Cianan (St. Louis, Mo), filed on October 12, 2020, was made available online on April 15, 2021. The patent's assignee is Tricentum Technologies LLC (St. Louis, Missouri, United States). News editors obtained the following quote from the background information supplied by the inventors: "Every year 13 million people in the United States engage in self-management of a medical condition involving self-injection of a medication. There are a significant number of these patients which also suffer a condition resulting in reduced dexterity or handgrip strength, have tremors, have fear of inadvertent injury, and/or have diminished ability to learn proper technique for insulin injection. Many patients who self-inject use disposable hypodermic needles with proactive sheaths. In this patient population, unsheathing and resheathing the needle can cause an increased risk of needle stick injuries (NSIs) and/or contamination of the tip.
机译:2021年5月05 (NewsRx)——由一个新闻记者新闻编辑在日常——从疾病预防华盛顿特区,NewsRx记者报告说专利申请的发明人Sabo沙龙(圣路易斯,密苏里州);密苏里州),申请10月12日,2020年2021年4月15日,网上。受让人Tricentum技术有限责任公司(St。路易斯,密苏里州,美国)。获得以下引用的背景信息提供的发明家:“每一个一年有1300万人在美国参与自我管理的医疗条件涉及self-injection的药物。大量的病人吗也有条件导致减少灵巧、握力震动,有害怕无意的伤害,和/或有吗降低学习能力适当的技术胰岛素注射。使用一次性皮下注射针头和积极主动鞘。和resheathing针会导致增加针刺伤的风险(NSIs)和(或)污染的小费。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号